Technical Analysis for SOLY - Soliton, Inc.

Grade Last Price % Change Price Change
grade F 5.73 4.95% 0.27
SOLY closed up 4.95 percent on Friday, May 24, 2019, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical SOLY trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction 4.95%
Lower Bollinger Band Walk Weakness 4.95%
Wide Bands Range Expansion 4.95%
Oversold Stochastic Weakness 4.95%

Older signals for SOLY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
Soliton, Inc. is a pre-revenue stage medical device company with a novel and proprietary platform technology licensed from MD Anderson. The Company’s first commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos. The Company is based in Houston, Texas, and is actively engaged in bringing this device to the market. The Company expects to file for premarket clearance with the U.S. Food and Drug Administration ("FDA") for its first device in the first quarter of 2019 and expects to receive clearance to market the device in mid-2019.
Health Medical Device Platform Technology
Is SOLY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 20 How to Invest In Tattoo Removal: Soliton
May 17 BIDU, CRAY, VNET and TIGR among midday movers
May 17 Soliton Responds To Blog Calling It A 'PR Machine'
May 17 Citius Pharmaceuticals and Soliton among healthcare gainers; CEL-SCI and BioPharmX among losers
May 17 ACHN and CRAY among premarket gainers
May 17 Soliton Provides FDA Update and Addresses Recent Anonymous Article
May 17 63 Biggest Movers From Yesterday
May 16 Microcaps mostly among midday movers
May 16 Iovance Biotherapeutics leads healthcare gainers; EDAP TMS and Cellectar Biosciences among losers
May 16 Soliton down 20% on bearish WDR report
See more SOLY news...
Indicators
Indicator Value
52 Week High 15.0
52 Week Low 4.12
Average Volume 265,762
200-Day Moving Average 0.0
50-Day Moving Average 10.0244
20-Day Moving Average 9.8305
10-Day Moving Average 7.621
Average True Range 1.2262
ADX 31.42
+DI 15.6871
-DI 35.2325
Chandelier Exit (Long, 3 ATRs ) 10.0914
Chandelier Exit (Short, 3 ATRs ) 8.6886
Upper Bollinger Band 15.3203
Lower Bollinger Band 4.3407
Percent B (%b) 0.13
BandWidth 111.689131
MACD Line -1.4072
MACD Signal Line -0.6738
MACD Histogram -0.7333
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.57
Resistance 3 (R3) 6.56 6.28 6.43
Resistance 2 (R2) 6.28 6.06 6.28 6.38
Resistance 1 (R1) 6.00 5.93 6.14 6.01 6.34
Pivot Point 5.72 5.72 5.79 5.72 5.72
Support 1 (S1) 5.44 5.50 5.58 5.45 5.12
Support 2 (S2) 5.16 5.37 5.16 5.08
Support 3 (S3) 4.88 5.16 5.03
Support 4 (S4) 4.89